Draper Secures ARPA-H Funding to Revolutionize Cold-Chain Management for Cell Therapies#ARPA-H#Biologics#Draper_Laboratory
Draper Secures ARPA-H Funding to Revolutionize Cold-Chain Management for Cell Therapies
Draper has been awarded up to $7.3 million from ARPA-H to innovate cold-chain logistics for biologics. This funding aims to stabilize cell therapies for greater accessibility.
third-news.com
October 7, 2026 at 4:25 PM
Draper Secures ARPA-H Funding to Revolutionize Cold-Chain Management for Cell Therapies#ARPA-H#Biologics#Draper_Laboratory